| Year |
Citation |
Score |
| 2019 |
Thomas ST, Louie GV, Lubin JW, Lundblad V, Noel JP. Substrate specificity and engineering of mevalonate 5-phosphate decarboxylase. Acs Chemical Biology. PMID 31268677 DOI: 10.2210/Pdb6N0X/Pdb |
0.4 |
|
| 2018 |
Henry LK, Thomas ST, Widhalm JR, Lynch JH, Davis TC, Kessler SA, Bohlmann J, Noel JP, Dudareva N. Contribution of isopentenyl phosphate to plant terpenoid metabolism. Nature Plants. PMID 30127411 DOI: 10.1038/S41477-018-0220-Z |
0.429 |
|
| 2015 |
Henry LK, Gutensohn M, Thomas ST, Noel JP, Dudareva N. Orthologs of the archaeal isopentenyl phosphate kinase regulate terpenoid production in plants. Proceedings of the National Academy of Sciences of the United States of America. PMID 26216978 DOI: 10.1073/Pnas.1504798112 |
0.435 |
|
| 2014 |
Yang M, Guja KE, Thomas ST, Garcia-Diaz M, Sampson NS. A distinct MaoC-like enoyl-CoA hydratase architecture mediates cholesterol catabolism in Mycobacterium tuberculosis. Acs Chemical Biology. 9: 2632-45. PMID 25203216 DOI: 10.1021/Cb500232H |
0.718 |
|
| 2014 |
Wipperman MF, Sampson NS, Thomas ST. Pathogen roid rage: cholesterol utilization by Mycobacterium tuberculosis. Critical Reviews in Biochemistry and Molecular Biology. 49: 269-93. PMID 24611808 DOI: 10.3109/10409238.2014.895700 |
0.684 |
|
| 2013 |
Dellas N, Thomas ST, Manning G, Noel JP. Discovery of a metabolic alternative to the classical mevalonate pathway. Elife. 2: e00672. PMID 24327557 DOI: 10.7554/Elife.00672 |
0.498 |
|
| 2013 |
Wipperman MF, Yang M, Thomas ST, Sampson NS. Shrinking the FadE proteome of Mycobacterium tuberculosis: insights into cholesterol metabolism through identification of an α2β2 heterotetrameric acyl coenzyme A dehydrogenase family. Journal of Bacteriology. 195: 4331-41. PMID 23836861 DOI: 10.1128/Jb.00502-13 |
0.688 |
|
| 2013 |
Thomas ST, Sampson NS. Mycobacterium tuberculosis utilizes a unique heterotetrameric structure for dehydrogenation of the cholesterol side chain. Biochemistry. 52: 2895-904. PMID 23560677 DOI: 10.1021/Bi4002979 |
0.749 |
|
| 2013 |
Slayden RA, Jackson M, Zucker J, Ramirez MV, Dawson CC, Crew R, Sampson NS, Thomas ST, Jamshidi N, Sisk P, Caspi R, Crick DC, McNeil MR, Pavelka MS, Niederweis M, et al. Updating and curating metabolic pathways of TB. Tuberculosis (Edinburgh, Scotland). 93: 47-59. PMID 23375378 DOI: 10.1016/J.Tube.2012.11.001 |
0.628 |
|
| 2013 |
Dellas N, Thomas ST, Manning G, Noel JP. Author response: Discovery of a metabolic alternative to the classical mevalonate pathway Elife. DOI: 10.7554/Elife.00672.023 |
0.41 |
|
| 2011 |
Thomas ST, VanderVen BC, Sherman DR, Russell DG, Sampson NS. Pathway profiling in Mycobacterium tuberculosis: elucidation of cholesterol-derived catabolite and enzymes that catalyze its metabolism. The Journal of Biological Chemistry. 286: 43668-78. PMID 22045806 DOI: 10.1074/Jbc.M111.313643 |
0.737 |
|
| 2011 |
Thomas ST, Yang X, Sampson NS. Inhibition of the M. tuberculosis 3β-hydroxysteroid dehydrogenase by azasteroids. Bioorganic & Medicinal Chemistry Letters. 21: 2216-9. PMID 21439822 DOI: 10.1016/J.Bmcl.2011.03.004 |
0.705 |
|
| Show low-probability matches. |